KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Potential bias in the clinical trial registration of patients with peripheral small-sized non-small cell lung cancer: Real-world data in the era of segmentectomy.

Yuji Nomata, Shota Nakamura, Keita Nakanishi, Yuka Kadomatsu, Harushi Ueno, Taketo Kato, Tetsuya Mizuno, Toyofumi Fengshi Chen-Yoshikawa

Surg Today 10.1007/s00595-026-03259-3

PMID41774196
PMCID-
DOI10.1007/s00595-026-03259-3
发表日期2026-03-03
摘要

摘要

PURPOSE: Recent phase III trials demonstrate that survival after segmentectomy is not inferior to that after lobectomy for peripheral small-sized non-small cell lung cancer (NSCLC). However, the influence of patient selection and registration bias remains unclear. This study analyzed real-world data to assess patients who were eligible for the JCOG0802/WJOG4607L trial, but who were not enrolled. METHODS: We analyzed data on 38 of 61 patients not enrolled in the JCOG0802/WJOG4607L trial, during its enrollment period. Surgical procedures, clinical characteristics, and outcomes of the nonregistered patients were reviewed. RESULTS: Lobectomy was performed in 31 patients and segmentectomy was performed in 7 patients. Radiological features of higher-grade malignancy were seen more frequently in the patients who underwent lobectomy. The most common reason for nonregistration in the JCOG0802/WJOG4607L trial was multiple mild comorbidities (n = 11), followed by tumor aggressiveness (n = 6), and concerns about inadequate margins with segmentectomy (n = 6). Recurrence was found in five patients. The 5-year overall and recurrence-free survival rates were 82.9% and 80.2%, respectively. CONCLUSIONS: Our analysis emphasizes the challenges posed by registration bias in clinical trials. Survival outcomes among the study population were worse than those reported in the JCOG0802/WJOG4607L trial, suggesting a high malignant potential on preoperative imaging, and that registration bias occurs even in large-scale randomized trials.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。